I agree that this site is using cookies. You can find further informations here.
X
Karen C. Wolff
5052  results:
Search for persons X
?
1

Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhib..:

Dayan Elshan, N. G. R. ; Wolff, Karen C. ; Riva, Laura...
Journal of Medicinal Chemistry.  , 2024
Link: https://doi.org/10.1021/..
 
?
2

Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL..:

Elshan, N. G. R. Dayan ; Wolff, Karen C. ; Riva, Laura...
Journal of Medicinal Chemistry.  67 (2024)  12 - p. 10508-10509 , 2024
Link: https://doi.org/10.1021/..
 
?
3

Antiviral drug screen identifies DNA-damage response inhibi..:

Garcia Jr., Gustavo ; Sharma, Arun ; Ramaiah, Arunachalam...
Cell Reports.  35 (2021)  1 - p. 108940 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Drug repurposing screens identify chemical entities for the..:

Bakowski, Malina A. ; Beutler, Nathan ; Wolff, Karen C....
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Dexamethasone inhibits respiratory syncytial virus-driven m..:

McAllister, Christopher S. ; Ansaldi, Dan ; Growcott, Ellena J....
Virology.  540 (2020)  - p. 195-206 , 2020
Link: https://doi.org/10.1016/..
 
?
6

RNA adenosine deaminase ADAR1 deficiency leads to increased..:

Li, Zhiqun ; Wolff, Karen C. ; Samuel, Charles E.
Virology.  396 (2010)  2 - p. 316-322 , 2010
Link: https://doi.org/10.1016/..
 
?
7

Identification of novel therapeutic targets for HIV infecti..:

Nguyen, Deborah G. ; Yin, Hong ; Zhou, Yingyao...
Virology.  362 (2007)  1 - p. 16-25 , 2007
Link: https://doi.org/10.1016/..
 
?
8

Vaccinia Virus E3L Interferon Resistance Protein Inhibits t..:

Liu, Yong ; Wolff, Karen C. ; Jacobs, Bertram L..
Virology.  289 (2001)  2 - p. 378-387 , 2001
Link: https://doi.org/10.1006/..
 
?
9

Discovery of CMX990: A Potent SARS-CoV‑2 3CL Protease Inhib..:

N. G. R. Dayan Elshan ; Karen C. Wolff ; Laura Riva...
doi:10.1021/acs.jmedchem.3c01938.s001.  , 2024
Link: https://doi.org/10.1021/..
 
?
10

Discovery of CMX990: A Potent SARS-CoV‑2 3CL Protease Inhib..:

N. G. R. Dayan Elshan ; Karen C. Wolff ; Laura Riva...
doi:10.1021/acs.jmedchem.3c01938.s002.  , 2024
Link: https://doi.org/10.1021/..
 
?
11

Discovery of CMX990: A Potent SARS-CoV‑2 3CL Protease Inhib..:

N. G. R. Dayan Elshan ; Karen C. Wolff ; Laura Riva...
doi:10.1021/acs.jmedchem.3c01938.s001.  , 2024
Link: https://doi.org/10.1021/..
 
?
12

Discovery of CMX990: A Potent SARS-CoV‑2 3CL Protease Inhib..:

N. G. R. Dayan Elshan ; Karen C. Wolff ; Laura Riva...
doi:10.1021/acs.jmedchem.3c01938.s002.  , 2024
Link: https://doi.org/10.1021/..
 
?
13

Drug repurposing screens identify chemical entities for the..:

Bakowski, Malina A ; Beutler, Nathan ; Wolff, Karen C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175350/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Drug repurposing screens identify chemical entities for the..:

Malina A. Bakowski ; Nathan Beutler ; Karen C. Wolff...
https://doi.org/10.1038/s41467-021-23328-0.  , 2021
Link: https://doi.org/10.1038/..
 
?
15

Antiviral drug screen identifies DNA-damage response inhibi..:

Garcia, Gustavo ; Sharma, Arun ; Ramaiah, Arunachalam...
qt3wv4q7vv.  , 2021
Link: https://escholarship.org..
 
1-15